The data shown was taken in each case from the latest announcement communicated by the shareholder.
Ordinary Shares:
By order of the Federal Court of Justice (Bundesgerichtshof) dated February 10, 2026 (Case No. II ZB 10/24), the ordinary shares of Biotest GmbH & Co. KGaA that were not yet owned directly or indirectly by Grifols S.A. were transferred to Grifols S.A. pursuant to Sections 39a (1), sentence 1, and 39b (5), sentence 3 of the German Securities Acquisition and Takeover Act (WpÜG). Since then, Grifols S.A. has directly or indirectly held 100% of the ordinary shares of Biotest GmbH & Co. KGaA.
Preference Shares:
As of 31 December 2025:
| 61.56% | Grifols S.A.*** |
| 38.44% | Freefloat |
*** As of 31 December 2025, Grifols S.A. (amongst other via Grifols Biotest Holding GmbH) held 61.56% of the preference shares in Biotest. (Source: Grifols S.A.)